Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion type Assertion NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_head.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion wasGeneratedBy ECO_0000203 NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion wasDerivedFrom befree-20140225 NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion SIO_000772 10916088 NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion evidence source_evidence_literature NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.
- NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.